Harry T Orr

Title: Harry T Orr: Innovator in Ataxia Research

Introduction

Harry T Orr is a prominent inventor based in Minneapolis, MN (US), known for his significant contributions to the field of ataxia research. With a total of 4 patents, Orr has focused on developing therapeutic compositions and methods aimed at treating ataxia, a neurological condition that affects coordination and balance.

Latest Patents

Orr's latest patents include innovative methods for treating ataxia. One notable patent is for "Ataxia therapeutic compositions and methods," which describes a method for treating individuals at risk of ataxia by administering a composition that includes a cholecystokinin receptor (Cck1R) agonist. This composition is effective in ameliorating symptoms associated with ataxia. Another significant patent is for the "Gene sequence for spinocerebellar ataxia type 1 and method for diagnosis." This invention provides an isolated DNA molecule of the autosomal dominant spinocerebellar ataxia type 1 gene, located on the short arm of chromosome 6. The isolated sequences contain a CAG repeat region, which is crucial for diagnosing the condition.

Career Highlights

Throughout his career, Harry T Orr has worked with esteemed institutions, including the Regents of the University of Minnesota and Baylor College of Medicine. His research has significantly advanced the understanding of ataxia and its genetic underpinnings.

Collaborations

Orr has collaborated with notable scientists in the field, including Huda Y Zoghbi and Laura P Ranum. These collaborations have further enriched his research and contributed to the development of effective treatments for ataxia.

Conclusion

Harry T Orr's innovative work in ataxia research has led to important advancements in therapeutic methods and genetic understanding of the condition. His contributions continue to impact the field and offer hope for those affected by ataxia.